日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice

肠道人类羧酸酯酶 2 (CES2) 表达挽救了整体 Ces2 簇敲除小鼠的药物代谢和大多数代谢综合征表型

Yao-Geng Wang, Chang-Pei Gan, Joke Beukers-Korver, Hilde Rosing, Wen-Long Li, Els Wagenaar, Maria C Lebre, Ji-Ying Song, Colin Pritchard, Rahmen Bin Ali, Ivo Huijbers, Jos H Beijnen, Alfred H Schinkel

Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism

羧酸酯酶 1 家族敲除改变药物分布和脂质代谢

Changpei Gan, Jing Wang, Alejandra Martínez-Chávez, Michel Hillebrand, Niels de Vries, Joke Beukers, Els Wagenaar, Yaogeng Wang, Maria C Lebre, Hilde Rosing, Sjoerd Klarenbeek, Rahmen Bin Ali, Colin Pritchard, Ivo Huijbers, Jos H Beijnen, Alfred H Schinkel

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women

在招募绝经前女性的乳腺癌窗口期试验中,基于IHC的Ki67作为他莫昔芬疗效的生物标志物

Stacey E P Joosten ,Marius Wellenstein ,Rutger Koornstra ,Annelot van Rossum ,Joyce Sanders ,Vincent van der Noort ,Maria C Ferrandez ,Rolf Harkes ,Ingrid A M Mandjes ,Hilde Rosing ,Alwin Huitema ,Jos H Beijnen ,Jelle Wesseling ,Paul J van Diest ,Hugo M Horlings ,Sabine C Linn ,Wilbert Zwart

P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib

P-糖蛋白 (ABCB1/MDR1) 控制 PARP1/2 抑制剂尼拉帕尼的脑渗透和肠道分布

Margarida L F Martins, Nancy H C Loos, Sümeyra Mucuk, Danielle de Jong, Maria C Lebre, Hilde Rosing, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel

Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry

使用液相色谱-串联质谱法开发和验证用于定量分析人类和小鼠基质中的 CDK4/6 抑制剂 abemaciclib、palbociclib 和 ribociclib 的生物分析方法

Alejandra Martínez-Chávez, Hilde Rosing, Michel Hillebrand, Matthijs Tibben, Alfred H Schinkel, Jos H Beijnen